Skip to main content
AURX
OTC Industrial Applications And Services

Nuo Posts 80% Q3 Revenue Growth, Wins 7% Medicare Reimbursement Increase for 2027

Arie Shkolnikov · Analysis by Wiseek AI
More coverage: Industrial
Sentiment info
Positive
Importance info
7
Price
$1.09
Mkt Cap
$52.958M
52W Low
$0.77
52W High
$3.23
52W Position info
42% above low
Off High info
66% below high
Rel. Volume info
0.1× avg
Market data snapshot near publication time

AURX sits 42% above its 52-week low of $0.77 on light trading volume (0.1× avg).

Summary

Nuo grew Q3 revenue 80% to $1.87M and cut its net loss to $424,928, while final 2027 Medicare rates raise the hospital outpatient payment about 7% and extend coverage to nursing homes from January 1, 2027. Cash of just $80,941 leaves the company dependent on new capital.


Key Events · Earnings and Guidance · AURX

  • Q3 Revenue Up 80% to $1.87M

    Total revenue rose to $1,866,125 from $1,032,096 a year earlier, and the net loss narrowed to $424,928 from $537,919.

  • 2027 Medicare Rates Set

    The final OPPS rule lifts the G0465 national average to approximately $2,257 per treatment, about 7% above 2026, while the physician fee schedule rate falls about 4% to approximately $1,020.

  • Nursing Home Coverage From 2027

    Medicare will process G0465 claims for nursing home treatments (Place of Service 32) effective January 1, 2027, which management expects to support growth.

  • Cash of $80,941 Against $2.45M Current Liabilities

    Cash fell to $80,941 from $548,946 at year-end 2025, and management says it is assessing opportunities to strengthen the capital structure.


Analysis · AURX · Industrial Applications And Services

The headline is the 2027 Medicare rulings, not the quarter. Revenue grew fast — $1.87M in Q3, up 80% — and the loss narrowed to $424,928, but the balance sheet is the real story: $80,941 of cash against $2.45M of current liabilities. Under the final OPPS rule, the hospital outpatient rate for G0465 rises about 7% to roughly $2,257 per treatment; the physician fee schedule rate falls about 4% to roughly $1,020; and nursing-home claims become payable starting January 1, 2027. Those rates set what Nuo gets paid per treatment next year, so they matter more than the quarter itself. Management explicitly says it is assessing ways to strengthen the capital structure, which points to a financing before the cash position is resolved.

How filings like this one have moved

In the 30 days to Nov 15, 2026, 37.5% of the 3713 measured filings Wiseek scored 7 moved their stock by 5% or more by the next session's close. The median move was 0.00%. These are measured outcomes after filings of this importance, not a forecast for this one.

Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset

At the time of this filing, AURX was trading at $1.09 on OTC in the Industrial Applications And Services sector, with a market capitalization of approximately $53M. The 52-week trading range was $0.77 to $3.23. This filing was assessed with positive market sentiment and an importance score of 7 out of 10.

View Main SEC Filing

Price Chart

Share this article

Copied!

AURX - Latest Insights

AURX
Nov 13, 2026, 5:17 PM EST
Filing Type: 10-Q
Importance Score:
8
Price at Filing: $1.09
Real-time Price: $1.09 info
Change: $0 (0%) info
Market Cap: $52.958M info
AURX
Aug 17, 2026, 8:00 AM EDT
Source: GlobeNewswire
Importance Score:
7
Price at Filing: $0.770
Real-time Price: $1.09 info
Change: +$0.320 (+42%) info
Market Cap: $52.958M info
AURX
Aug 17, 2026, 7:55 AM EDT
Filing Type: 8-K
Importance Score:
7
Price at Filing: $0.770
Real-time Price: $1.09 info
Change: +$0.320 (+42%) info
Market Cap: $52.958M info
AURX
Aug 14, 2026, 5:10 PM EDT
Filing Type: 10-Q
Importance Score:
8
Price at Filing: $0.770
Real-time Price: $1.09 info
Change: +$0.320 (+42%) info
Market Cap: $52.958M info
AURX
Jun 03, 2026, 11:04 AM EDT
Filing Type: SCHEDULE 13D/A
Importance Score:
8
Price at Filing: $1.06
Real-time Price: $1.09 info
Change: +$0.030 (+3%) info
Market Cap: $52.958M info